The extremely mutated SARS-CoV-2 BA.3.2 variant, which has been reported by a minimum of 23 nations as of February 11, has been detected in nasal swabs collected from 4 US vacationers, medical samples from 5 sufferers, three airplane wastewater samples, and 132 wastewater surveillance samples from 25 states, per a examine printed final week in Morbidity and Mortality Weekly Report.
First recognized in a respiratory pattern in South Africa in November 2024, the pressure has roughly 70 to 75 substitutions and deletions within the gene sequence of its spike protein relative to the JN.1 variant and its descendant, LP.8.1, the antigens used within the newest COVID-19 vaccines.
“BA.3.2 represents a brand new lineage of SARS-CoV-2, genetically distinct from the JN.1 lineages (together with LP.8.1 and XFG) which have circulated in the USA since January 2024,” wrote the authors, led by Facilities for Illness Management and Prevention (CDC) researchers. The CDC makes use of digital public well being surveillance to watch SARS-CoV-2 variants world wide.
30% prevalence in 3 European nations
Detections of BA.3.2 started rising in September 2025. The primary US identification of the pressure was on June 27, 2025, via the CDC’s Traveler-Primarily based Genomic Surveillance program in an individual touring to the USA from the Netherlands.
Continued genomic surveillance is required to trace SARS-CoV-2 evolution and decide its potential impact on public well being.
From November 2025 to January 2026, weekly BA.3.2 detections elevated to about 30% of sequences in Denmark, Germany, and the Netherlands. The primary US occasion of BA.3.2 in a medical specimen was documented on January 5, 2026. As of February 11, the pressure’s prevalence amongst 2,579 complete genetic sequences in nationwide surveillance collected beginning on December 1, 2025, was 0.19%.
“As a result of many nations have restricted genomic detection and surveillance capacities, these detections possible underrepresent the precise geographic extent of unfold,” the researchers wrote. “Phylogenetic analyses have recognized the emergence of two BA.3.2 sublineages (BA.3.2.1 and BA.3.2.2), indicating ongoing viral evolution.”
As BA.3.2 mutations within the spike protein may scale back safety from a vaccination or an infection, “continued genomic surveillance is required to trace SARS-CoV-2 evolution and decide its potential impact on public well being,” they added.
